Johanna Mercier
Vermögen: 18 Mio $ am 31.05.2026
Vermögen: 18 Mio $ am 31.05.2026
Frau Johanna Mercier ist Chief Commercial Officer bei Gilead Sciences, Inc. und Mitglied bei World 50, Inc. Sie ist Mitglied des Verwaltungsrats von Neurocrine Biosciences, Inc. und des Leonard D Schaeffer Center For Health Policy & Economics sowie des Robert Wood Johnson University Hospital, Inc. Frau Mercier war zuvor als President-US Commercial bei Bristol Myers Squibb Co. beschäftigt. Sie erhielt ihren Bachelor-Abschluss von der University of Montral und einen MBA von der Concordia University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GILEAD SCIENCES, INC. 0,01 % | 15.06.2026 | 124.234 ( 0,01 % ) | 17 Mio $ | 31.05.2026 |
| 27.05.2026 | 6.853 ( 0,01 % ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.07.2019 |
| NEUROCRINE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 15.04.2021 |
| ARCUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 29.01.2024 |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | - |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.06.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Technology Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen